Bharat Biotech unveils world’s first intranasal COVID-19 vaccine ‘iNCOVACC’
iNCOVACC is a cost-effective vaccine that utilizes a vector-based platform, which can be easily updated with emerging variants leading to large-scale production.
ADVERTISEMENT
Latest News
- Factbox-From Australia to Israel, Adani Group...
22 Nov, 2024
- What you need to know about...
22 Nov, 2024
- Indian Americans launch LetzFarm app to...
22 Nov, 2024
- Trump considers Warsh for Treasury Secretary...
22 Nov, 2024
- Call for transparency after Matt Gaetz...
22 Nov, 2024
- Talk on emerging tech and Indian...
22 Nov, 2024
- Vegan Thanksgiving: World Vegan Vision promotes...
22 Nov, 2024
- London to hold exhibition on history...
22 Nov, 2024
- Indian-American researcher proposes groundbreaking theory on...
22 Nov, 2024
- Four South Asians wanted across Canada...
22 Nov, 2024
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login